Page last updated: 2024-08-22

copper sulfate and Bone Marrow Diseases

copper sulfate has been researched along with Bone Marrow Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Dong, C; Gong, R; Jiang, B; Li, G; Lu, Y; Ma, Y; Qiao, Z; Wang, Y; Zhang, L; Zhang, Y; Zheng, Z1
Mandal, M; Ramachandran, S1

Other Studies

2 other study(ies) available for copper sulfate and Bone Marrow Diseases

ArticleYear
Uvangoletin induces mitochondria-mediated apoptosis in HL-60 cells in vitro and in vivo without adverse reactions of myelosuppression, leucopenia and gastrointestinal tract disturbances.
    Oncology reports, 2016, Volume: 35, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Diseases; Columbidae; Copper Sulfate; Cyclophosphamide; Drugs, Chinese Herbal; Ethanol; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukopenia; Mice; Mice, Nude; Mitochondria; Nausea; Neoplasm Proteins; Random Allocation; Rats; Stomach Ulcer; Xenograft Model Antitumor Assays

2016
Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Ascites; Azurin; Bone Marrow Diseases; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Copper Sulfate; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Lymphoma, Non-Hodgkin; Male; Mice; Oxidation-Reduction; Pseudomonas aeruginosa; Weight Loss

2011